PC
PTCT icon

Pier Capital’s PTC Therapeutics PTCT Stock Holding History

Pier Capital’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-71,873
Closed -$4.39M – 126
2020
Q4 		$4.39M Sell
71,873
-4,518
-6% -$266K 0.46% 97
2020
Q3 		$3.57M Sell
76,391
-41,057
-35% -$2.02M 0.52% 94
2020
Q2 		$5.96M Buy
117,448
+29,395
+33% +$1.44M 0.95% 60
2020
Q1 		$3.93M Buy
88,053
+11,625
+15% +$585K 0.87% 58
2019
Q4 		$3.67M Buy
+76,428
New +$3.25M 0.6% 84
2014
Q3 		– Sell
-135,445
Closed -$3.54M – 156
2014
Q2 		$3.54M Buy
+135,445
New +$2.9M 0.5% 91

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pier Capital's PTCT Position: Q1 2021 in Review

Pier Capital sold out of PTC Therapeutics (PTCT) in Q1 2021, closing a stake of 71,873 shares — an estimated $4.39M sold.

Pier Capital first reported a position in PTCT in Q2 2014 and held it in 6 quarters. The position peaked at $5.96M in Q2 2020. 207 funds tracked by Wall St. Rank hold PTCT as of Q1 2021.

  • Pier Capital reported no remaining PTC Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Pier Capital sold 71,873 PTC Therapeutics shares in Q1 2021, an estimated $4.39M.
  • Pier Capital first reported a position in PTC Therapeutics in Q2 2014 and held it in 6 quarters.
  • Pier Capital's PTC Therapeutics position peaked at $5.96M in Q2 2020.
  • 207 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2021.

Based on Pier Capital's 13F filing for Q1 2021, filed 13 May 2021.